Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0001209191-23-055721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-17 | 2023-11-15 | DLB | Couling John D | SVP, Entertainment | S - Sale | $88.58 | -79 | 96.4K | -0.1% | -$6,998 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-11-15 | S | D | 79 | $88.58 | 96,370 | D | — | — | (F1) Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest. (F2) Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023. The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error. |